| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.36 | 6e-14 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-14 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-14 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.29 | 2e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |